Related content

Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma

By Yasuda Takashi   Kamigaki Takashi   Kawasaki Kentaro   Nakamura Tetsu   Yamamoto Masashi   Kanemitsu Kiyonori   Takase Shiro   Kuroda Daisuke   Kim Yongsik   Ajiki Tetsuo   Kuroda Yoshikazu  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1025-1036

Springer Publishing Company

Access to resources Recommend Favorite

Generation of dendritic cell–tumor cell hybrids by electrofusion for clinical vaccine application

By Trevor Katrina   Cover Cathleen   Ruiz Yvette   Akporiaye Emmanuel   Hersh Evan   Landais Didier   Taylor Rachel   King Alan   Walters Richard  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 705-714

Springer Publishing Company

Access to resources Recommend Favorite

Mesenchymal stem cell-tumor cell cooperation in breast cancer vasculogenesis

By      

Molecular Medicine Reports, Vol. 5, Iss. 5, 2012-01 ,pp. : 1175-1180

Spandidos Publications

Access to resources Recommend Favorite

Clinical applications of dendritic cell vaccination in the treatment of cancer

By Cranmer Lee   Trevor Katrina   Hersh Evan  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 275-306

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT

By Ou Xueling   Cai Shaohui   Liu Peng   Zeng Jun   He Yuwen   Wu Xinyao   Du Jun  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 525-533

Springer Publishing Company

Access to resources Recommend Favorite